Literature DB >> 2300976

Continuous lidocaine infusion and focal feline cerebral ischemia.

M T Shokunbi1, A W Gelb, X M Wu, D J Miller.   

Abstract

We measured somatosensory evoked potentials, infarct size, and cerebral blood flow in 20 cats subjected to occlusion of the middle cerebral artery for 3 hours, followed by an equal period of reperfusion. The cats were randomized into a treatment group that received a continuous infusion of 2 mg/kg lidocaine hydrochloride or a control group that received an equivalent volume of normal saline. All 10 treated cats retained measurable evoked potentials throughout the experiment. In five control cats, evoked potentials disappeared completely at some point during the occlusion (difference between groups significant at p less than 0.001). Mean amplitude of the major cortical wave in the nine treated cats with cerebral infarcts was higher than that of the nine corresponding controls (p less than 0.05). Lidocaine reduced the mean +/- SEM size of the infarcts from 30.1 +/- 6.0% in the control group to 14.7 +/- 4.9% in the treated group (p less than 0.05). As blood flow was reduced in the infarct and peri-infarct zones in the control but not the treated cats, our results suggest that the beneficial effects of lidocaine may be due to preservation of blood flow in the ischemic zone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300976     DOI: 10.1161/01.str.21.1.107

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

Review 1.  Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.

Authors:  Andrew M Slupe; Jeffrey R Kirsch
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-16       Impact factor: 6.200

2.  Neuroprotection after major cardiovascular surgery.

Authors:  Jose Torres; Koto Ishida
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

3.  Regional lidocaine infusion reduces postischemic spinal cord injury in rabbits.

Authors:  A Z Apaydin; S Büket
Journal:  Tex Heart Inst J       Date:  2001

4.  Actions of the novel neuroprotective agent, lifarizine (RS-87476), on voltage-dependent sodium currents in the neuroblastoma cell line, N1E-115.

Authors:  J G McGivern; L Patmore; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  The importance of sodium for anoxic transmission damage in rat hippocampal slices: mechanisms of protection by lidocaine.

Authors:  E Fried; P Amorim; G Chambers; J E Cottrell; I S Kass
Journal:  J Physiol       Date:  1995-12-01       Impact factor: 5.182

Review 6.  Neuroprotective effect of lidocaine: is there clinical potential?

Authors:  Tiandong Leng; Xiuren Gao; James P Dilger; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25

7.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 8.  Lignocaine: neuro-protective or wishful thinking?

Authors:  Simon J Mitchell; Alan F Merry
Journal:  J Extra Corpor Technol       Date:  2009-03

9.  Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers.

Authors:  Chiara Tarracchini; Christian Milani; Vassilios Fanos; Marco Ventura; Giulia Longhi; Federico Fontana; Leonardo Mancabelli; Roberta Pintus; Gabriele Andrea Lugli; Giulia Alessandri; Rosaria Anzalone; Alice Viappiani; Francesca Turroni; Michele Mussap; Angelica Dessì; Flaminia Cesare Marincola; Antonio Noto; Anna De Magistris; Marine Vincent; Sergio Bernasconi; Jean-Charles Picaud
Journal:  Microbiol Spectr       Date:  2021-10-27

10.  Antioxidant effect of lidocaine and procaine on reactive oxygen species-induced endothelial dysfunction in the rabbit abdominal aorta.

Authors:  Jae Myeong Lee; Jung Kook Suh; Ji Seon Jeong; Sang Yun Cho; Dong Won Kim
Journal:  Korean J Anesthesiol       Date:  2010-08-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.